TELA Bio - רווח נקי למניה בארבעת הרבעונים האחרונים TELA

TELA Bio, Inc. (TELA) produces surgical meshes and biomaterials at US contract manufacturing plants, utilizing its own warehouses in Pennsylvania to control supplies. The company aims to dominate the soft tissue reconstruction segment by promoting the OviTex system as a safe alternative to synthetics. This price action chart reflects an EPS TTM of 15.80, while the business relies on a diversified network of external suppliers to minimize production risks.
TELA Bio Corp - פילוחים אנליטיים ומדדי מפתח (TELA)

To select high-quality assets, investors must separate speculative noise from actual profit dynamics. By analyzing the annual EPS (TTM) growth statistics, which compare current net income per share with the same period last year, one can confirm the sustainable demand for the non-cyclical bioimplants of TELA Bio, Inc. (TELA), eliminating accounting manipulations and assessing the fundamental macro-stability of the business through this chart.